Literature DB >> 30541821

Drug samples in family medicine teaching units: a cross-sectional descriptive study: Part 3: availability and use of drug samples in Quebec.

Marie-Thérèse Lussier1, Fatoumata Binta Diallo2, Pierre Pluye3, Roland Grad4, Andréa Lessard5, Caroline Rhéaume6, Michel Labrecque7.   

Abstract

OBJECTIVE: To draw a portrait of drug sample distribution and to assess the concordance between drug samples distributed and the medical problems encountered in the ambulatory primary health care setting.
DESIGN: Descriptive cross-sectional survey. A self-administered questionnaire was distributed to all health care professionals (HCPs) in family medicine teaching units (FMTUs) that kept drug samples between February and December 2013. Dispensers were defined as HCPs reporting the use of drug samples. Concurrently, an inventory log sheet was completed by managers of drug samples to document the contents of sample cabinets. Data from the Canadian Disease and Therapeutic Index were used as the criterion standard to assess the consistency between the drug samples found in the cabinets and the profile of the most frequent health problems encountered in primary care.
SETTING: All 33 FMTUs that kept drug samples in Quebec. PARTICIPANTS: Health care professionals authorized to hand out drug samples (practising physicians, residents, pharmacists, and nurses), and managers of drug sample cabinets. MAIN OUTCOME MEASURES: Dispensing practices of HCPs; number of doses of each drug contained in the sample cabinets; total market value of the samples; concordance between the drug sample categories made available and the most common medical problems encountered in primary care; and data on safe handling, ethical issues, effect of the pharmaceutical industry on prescribing behaviour, and inventory of samples.
RESULTS: Among 859 HCPs, 579 (67%) reported dispensing drug samples. A large proportion of dispensers (88%) were unable to find the specific drug they sought and half of them (51%) provided the patients with a drug sample even if it was not their first choice for treatment. The drug sample cabinet inventory revealed products from 292 different companies and identified a total of 382 363 medication doses for a total value of $201 872. We found gaps among types of drugs provided to patients, those the HCPs would consider useful, and those available in the cabinets.
CONCLUSION: Drug samples available in FMTUs do not meet the needs of many patients and HCPs, suggesting that the main driving force for drug sample distribution is not patient care. Policies on drug samples in FMTUs should be uniform across the province, and management should be as strict as in community pharmacies. Otherwise, prohibiting their use should be considered. Copyright© the College of Family Physicians of Canada.

Entities:  

Mesh:

Year:  2018        PMID: 30541821      PMCID: PMC6371885     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  21 in total

1.  Pharmaceutical starter samples.

Authors:  Peter G Teichman; Anne E Caffee
Journal:  J Am Board Fam Pract       Date:  2002 Nov-Dec

2.  Physician professionalism and changes in physician-industry relationships from 2004 to 2009.

Authors:  Eric G Campbell; Sowmya R Rao; Catherine M DesRoches; Lisa I Iezzoni; Christine Vogeli; Dragana Bolcic-Jankovic; Paola D Miralles
Journal:  Arch Intern Med       Date:  2010-11-08

3.  Do drug samples influence resident prescribing behavior? A randomized trial.

Authors:  Richard F Adair; Leah R Holmgren
Journal:  Am J Med       Date:  2005-08       Impact factor: 4.965

4.  Interactions of doctors with the pharmaceutical industry.

Authors:  M A Morgan; J Dana; G Loewenstein; S Zinberg; J Schulkin
Journal:  J Med Ethics       Date:  2006-10       Impact factor: 2.903

5.  Is your sample cupboard relevant to your practice?

Authors:  Geoffrey Spurling; Greg Kyle
Journal:  Aust Fam Physician       Date:  2007-03

6.  Many sample closet medications are expired.

Authors:  Kari L Evans; Steven R Brown
Journal:  J Am Board Fam Med       Date:  2012 May-Jun       Impact factor: 2.657

7.  A physician survey of the effect of drug sample availability on physicians' behavior.

Authors:  L D Chew; T S O'Young; T K Hazlet; K A Bradley; C Maynard; D S Lessler
Journal:  J Gen Intern Med       Date:  2000-07       Impact factor: 5.128

8.  Medicare beneficiaries and free prescription drug samples: a national survey.

Authors:  Jennifer Tjia; Becky A Briesacher; Stephen B Soumerai; Marsha Pierre-Jacques; Fang Zhang; Dennis Ross-Degnan; Jerry H Gurwitz
Journal:  J Gen Intern Med       Date:  2008-03-07       Impact factor: 5.128

9.  Characteristics of recipients of free prescription drug samples: a nationally representative analysis.

Authors:  Sarah L Cutrona; Steffie Woolhandler; Karen E Lasser; David H Bor; Danny McCormick; David U Himmelstein
Journal:  Am J Public Health       Date:  2008-01-02       Impact factor: 9.308

10.  Impact of pharmaceutical promotion on prescribing decisions of general practitioners in Eastern Turkey.

Authors:  Serhat Vancelik; Nazim E Beyhun; Hamit Acemoglu; Oksan Calikoglu
Journal:  BMC Public Health       Date:  2007-06-25       Impact factor: 3.295

View more
  2 in total

1.  Drug samples in family medicine teaching units: a cross-sectional descriptive study: Part 1: drug sample management policies and the relationship between the pharmaceutical industry and residents in Quebec.

Authors:  Caroline Rhéaume; Michel Labrecque; Nadine Moisan; Jacky Rioux; Émilie Tardieux; Fatoumata Binta Diallo; Marie-Thérèse Lussier; Andréa Lessard; Roland Grad; Pierre Pluye
Journal:  Can Fam Physician       Date:  2018-12       Impact factor: 3.275

2.  Reflective practice.

Authors:  Nicholas Pimlott
Journal:  Can Fam Physician       Date:  2018-12       Impact factor: 3.275

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.